Summary
Crystallization of calcium oxalate in the presence of uric acid and sodium urate crystals was analyzed in a metastable crystallization system containing calcium chloride and sodium oxalate (A), in urine highly supersaturated with respect to calcium oxalate (B), and in urine with a high level of metastable supersaturations (C). In system A uric acid crystals in concentrations up to 11.4 mMol/l did not affect calcium oxalate crystallization, neither did sodium urate during the first 6 h in concentrations below 5 mMol/l. In system B neither uric acid nor sodium urate crystals affected calcium oxalate crystallization. However, an increased rate of crystallization was observed with both uric acid and sodium urate in system C, but the effect was less pronounced than with calcium oxalate seed. Urine pre-treated with sodium urate and subsequently analyzed in system A in a concentration of 2%, gave a slightly lower inhibition of calcium oxalate crystal growth. Concerning the crystal size distribution in the same system, larger crystals were observed in several urines pre-treated with uric acid and sodium urate.
Similar content being viewed by others
References
Berthoux FC, Juge J, Genin C, Sabatier JC, Assenat H (1979) Double-blind trial of allopurinol as a preventive treatment in calcium urolithiasis. Mineral Electrolyte Metab 2:207–209
Berthoux FC, Juge J, Ducret F (1981) Double-blind trial of allopurinol as a preventive treatment in recurrent calcium nephrolithiasis. Mineral Electrolyte Metab 6:232
Brien G, Bick C (1977) Allopurinol in the recurrence prevention of calcium oxalate lithiasis. Eur Urol 3:35–36
Coe FL, Lawton RL, Goldstein RB, Tembe V (1975) Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med 149:926–929
Coe FL (1977) Treated and untreated recurrent calcium-nephrolithiasis in patients with idipathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med 87:404–410
Coe FL (1980) Hyperuricosuric calcium oxalate nephrolithiasis. In: Brenner BM, Stein JH (eds) Nephrolithiasis. Comtemporary issues in nephrology 5. Churchill Livingstone, pp 116–135
Editorial (1977) Allopurinol treatment for calcium stone disease. Br Med J 2:1302–1303
Fellström B (1981) Urate and renal calcium stone disease. Scand J Urol Nephrol Suppl 62:34–36
Finlayson B, Du Bois L (1978) Adsorption of heparin on sodium acid urate. Clin Chim Acta 84:203–206
Koutsoukos PG, Lam-Erwin CYC, Nancollas GH (1980) Epitaxial considerations in the urinary stone formation. I. The urate-oxalate-phosphate system. Invest Urol 18:179
Meyer JL, Bergert JH, Smith LH (1976) The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid. Invest Urol 14:115–119
Meyer JL (1981) Nucleation kinetics in the calcium oxalatesodium urate monohydrate system. Invest Urol 19:197–201
Miano L, Petta S, Gallucci M (1979) Allopurinol in the prevention of calcium oxalate renal stones. Eur Urol 5:229–232
Pak CYC, Arnold LH (1975) Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 149:930
Pak CYC, Holt K, Zerwekh JE (1979) Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation. Invest Urol 17:138–140
Pak CYC, Holt K, Britton F, Peterson R, Crowther C, Ward D (1980) Assessment of pathogenetic roles of uric acid, monopotassium urate, monoammonium urate and monosodium urate in hyperuricosuric calcium oxalate nephrolithiasis. Mineral Electrolyte Metab 4:130–136
Pak CYC (1982) Medical management of nephrolithiasis. J Urol 128:1157–1164
Robertson WG, Peacock M, Nordin BEC (1973) Inhibitors of crystal growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43:31–37
Robertson WG, Knowles F, Peacock M (1976) Urinary acid mucopolysaccharide inhibitors of calcium oxalate crystallization In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W (eds) Urolithiasis research. Plenum Press, New York, pp 331–334
Scott R, Mathieson A, McLelland A (1979) The reduction in stone recurrence and oxalate excretion by allopurinol. In: Rose GA, Robertson WG, Watts RWE (eds) Oxalate in human biochemistry and clinical pathology. London, pp 191–197
Smith MJV, Boyce WH (1969) Allopurinol and urolithiasis. J Urol 102:750–753
Smith MJV (1977) Placebo versus allpurinol for renal calculi. J Urol 117:690–692
Tiselius HG (1980) Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol. Br J Urol 52:189–192
Tiselius HG, Larsson L (1981) Urinary excretion of urate in patients with calcium oxalate stone disease. Urol Res 11:279–283
Tiselius HG, Larsson L (1981) Urine composition in patients with calcium oxalate stone disease during treatment with allopurinol. In: Vahlensieck W, Gasser G (eds) Pathogenese and Klinik der Harnsteine VIII. steinkopff, Darmstadt, pp 414–418
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tiselius, H.G. Effects of sodium urate and uric acid crystals on the crystallization of calcium oxalate. Urol. Res. 12, 11–15 (1984). https://doi.org/10.1007/BF00256303
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00256303